These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 8700224

  • 1. Cdc25 cell-cycle phosphatase as a target of c-myc.
    Galaktionov K, Chen X, Beach D.
    Nature; 1996 Aug 08; 382(6591):511-7. PubMed ID: 8700224
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

  • 6. Cell cycle: on target with Myc.
    Zörnig M, Evan GI.
    Curr Biol; 1996 Dec 01; 6(12):1553-6. PubMed ID: 8994810
    [Abstract] [Full Text] [Related]

  • 7. Involvement of Myc targets in c-myc and N-myc induced human tumors.
    Ben-Yosef T, Yanuka O, Halle D, Benvenisty N.
    Oncogene; 1998 Jul 16; 17(2):165-71. PubMed ID: 9674700
    [Abstract] [Full Text] [Related]

  • 8. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells.
    Wang Q, Zhang H, Kajino K, Greene MI.
    Oncogene; 1998 Oct 15; 17(15):1939-48. PubMed ID: 9788437
    [Abstract] [Full Text] [Related]

  • 9. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS.
    Cancer Res; 2000 Nov 15; 60(22):6318-25. PubMed ID: 11103792
    [Abstract] [Full Text] [Related]

  • 10. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.
    Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA.
    Oncogene; 1999 Feb 04; 18(5):1219-26. PubMed ID: 10022128
    [Abstract] [Full Text] [Related]

  • 11. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S, Sedivy JM.
    Cancer Res; 2001 Feb 01; 61(3):1178-86. PubMed ID: 11221849
    [Abstract] [Full Text] [Related]

  • 12. c-Myc-regulated microRNAs modulate E2F1 expression.
    O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT.
    Nature; 2005 Jun 09; 435(7043):839-43. PubMed ID: 15944709
    [Abstract] [Full Text] [Related]

  • 13. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C, Fernandez-Medarde A, Rojas JM, Font de Mora J, Esteban LM, Santos E.
    Oncogene; 1998 Feb 05; 16(5):613-24. PubMed ID: 9482107
    [Abstract] [Full Text] [Related]

  • 14. S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase.
    Spitkovsky D, Jansen-Dürr P, Karsenti E, Hoffman I.
    Oncogene; 1996 Jun 20; 12(12):2549-54. PubMed ID: 8700513
    [Abstract] [Full Text] [Related]

  • 15. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
    Huang A, Ho CS, Ponzielli R, Barsyte-Lovejoy D, Bouffet E, Picard D, Hawkins CE, Penn LZ.
    Cancer Res; 2005 Jul 01; 65(13):5607-19. PubMed ID: 15994933
    [Abstract] [Full Text] [Related]

  • 16. Function of the c-Myc oncogenic transcription factor.
    Dang CV, Resar LM, Emison E, Kim S, Li Q, Prescott JE, Wonsey D, Zeller K.
    Exp Cell Res; 1999 Nov 25; 253(1):63-77. PubMed ID: 10579912
    [Abstract] [Full Text] [Related]

  • 17. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q, Li J, Cenkci B, Kretzner L.
    Oncogene; 2004 Feb 05; 23(5):1088-97. PubMed ID: 14716294
    [Abstract] [Full Text] [Related]

  • 18. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
    Hernández S, Hernández L, Beà S, Cazorla M, Fernández PL, Nadal A, Muntané J, Mallofré C, Montserrat E, Cardesa A, Campo E.
    Cancer Res; 1998 Apr 15; 58(8):1762-7. PubMed ID: 9563496
    [Abstract] [Full Text] [Related]

  • 19. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N, Hill AD, Young LS.
    J Mol Endocrinol; 2006 Dec 15; 37(3):377-90. PubMed ID: 17170079
    [Abstract] [Full Text] [Related]

  • 20. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A, Millington M, Sun LQ, Symonds G.
    Cancer Gene Ther; 2000 Nov 15; 7(11):1491-503. PubMed ID: 11129291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.